SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/15/23 FSD Pharma Inc. 6-K 12/14/23 2:729K Blueprint/FA |
Document/Exhibit Description Pages Size 1: 6-K Current, Quarterly or Annual Report by a Foreign HTML 11K Issuer 2: EX-99.1 Material Change Report HTML 4K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2023
Commission File Number: 001-39152
(Registrant) |
199 Bay St., Suite 4000
Toronto, Ontario M5L 1A9 Canada
(Address of Principal Executive Offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
FSD PHARMA INC. | |||
| (Registrant) |
| |
Date December 14, 2023 | By: | /s/ Nathan Coyle | |
|
| ||
Chief Financial Officer |
2 |
Exhibit |
| Description of Exhibit |
|
3 |
This ‘6-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 12/15/23 | 6-K | ||
For Period end: | 12/14/23 | 6-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/20/24 FSD Pharma Inc. 424B5 2/16/24 1:863K RDG Filings/FA 12/26/23 FSD Pharma Inc. F-3 12/22/23 5:33M Blueprint/FA |